Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ROSG

(ROSG) (ROSG) Stock Price, News & Analysis

(ROSG) logo

About (ROSG) Stock (NASDAQ:ROSG)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.44
50-Day Range
$0.43
$0.43
52-Week Range
$0.23
$2.75
Volume
169,599 shs
Average Volume
81,512 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.

Receive ROSG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter.

ROSG Stock News Headlines

Something Big Is Coming...
Man who predicted Lehman Crash Warns "Get OUT of Cash" He predicted the 2008 crisis and recommended shorting Lehman for an 82% return in just five months... And he predicted the fall of the Nasdaq on the exact day it started crashing in 2021. Today, he's explaining why the dollar has lost more value in 2025 than in ANY year since Lehman collapsed.
Rosetta Genomics Ltd ROSGQ
See More Headlines

ROSG Stock Analysis - Frequently Asked Questions

(ROSG) (NASDAQ:ROSG) issued its earnings results on Thursday, May, 19th. The medical research company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The medical research company had revenue of $2.60 million for the quarter, compared to analyst estimates of $3.36 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ROSG) investors own include Agenus (AGEN), Bausch Health Companies (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and (SCMP) (SCMP).

Company Calendar

Last Earnings
5/19/2016
Today
6/16/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ROSG
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:ROSG) was last updated on 6/16/2025 by MarketBeat.com Staff
From Our Partners